IAP
ABBV icon

Indie Asset Partners’s AbbVie ABBV Stock Holding History

Indie Asset Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,468
Closed -$308K – 68
2025
Q1 		$308K Sell
1,468
-639
-30% -$124K 0.27% 61
2024
Q4 		$374K Buy
2,107
+8
+0.4% +$1.47K 0.29% 55
2024
Q3 		$414K Sell
2,099
-46
-2% -$8.59K 0.31% 55
2024
Q2 		$368K Sell
2,145
-891
-29% -$148K 0.29% 56
2024
Q1 		$553K Buy
3,036
+15
+0.5% +$2.58K 0.49% 36
2023
Q4 		$468K Buy
3,021
+6
+0.2% +$875 0.42% 33
2023
Q3 		$449K Sell
3,015
-24
-0.8% -$3.52K 0.45% 36
2023
Q2 		$409K Sell
3,039
-47
-2% -$6.89K 0.45% 38
2023
Q1 		$492K Sell
3,086
-430
-12% -$65.7K 0.57% 31
2022
Q4 		$568K Sell
3,516
-224
-6% -$34.3K 0.62% 32
2022
Q3 		$502K Sell
3,740
-165
-4% -$23.7K 0.51% 35
2022
Q2 		$598K Sell
3,905
-27
-0.7% -$4.13K 0.53% 33
2022
Q1 		$637K Buy
3,932
+123
+3% +$17.9K 0.48% 34
2021
Q4 		$516K Sell
3,809
-510
-12% -$60.2K 0.37% 46
2021
Q3 		$466K Buy
4,319
+675
+19% +$77.1K 0.38% 56
2021
Q2 		$410K Buy
3,644
+175
+5% +$19.7K 0.33% 63
2021
Q1 		$375K Buy
3,469
+690
+25% +$73.8K 0.43% 67
2020
Q4 		$298K Sell
2,779
-2,462
-47% -$237K 0.35% 71
2020
Q3 		$459K Sell
5,241
-50
-0.9% -$4.71K 0.57% 48
2020
Q2 		$489K Buy
5,291
+73
+1% +$6.43K 0.61% 43
2020
Q1 		$398K Sell
5,218
-794
-13% -$67.6K 0.5% 43
2019
Q4 		$532K Buy
+6,012
New +$499K 0.57% 41

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Indie Asset Partners's ABBV Position: Q2 2025 in Review

Indie Asset Partners sold out of AbbVie (ABBV) in Q2 2025, closing a stake of 1,468 shares — an estimated $308K sold.

Indie Asset Partners first reported a position in ABBV in Q4 2019 and held it in 22 quarters. The position peaked at $637K in Q1 2022. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

  • Indie Asset Partners reported no remaining AbbVie position as of Q2 2025 after selling out during the quarter.
  • Indie Asset Partners sold 1,468 AbbVie shares in Q2 2025, an estimated $308K.
  • Indie Asset Partners first reported a position in AbbVie in Q4 2019 and held it in 22 quarters.
  • Indie Asset Partners's AbbVie position peaked at $637K in Q1 2022.
  • 3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Indie Asset Partners's 13F filing for Q2 2025, filed 12 Aug 2025.